REACT: a randomized trial to assess the efficacy and safety of clazosentan for preventing clinical deterioration due to delayed cerebral ischemia after aneurysmal subarachnoid hemorrhageStephan A. Mayer, Manfred Westphal, Nicolas Bruder et al.|Journal of neurosurgery|2024Cited by 31
Sex-dependent characteristics and outcomes after clipping of unruptured intracranial aneurysms: a multicenter propensity score–matched studyRichard Drexler, Lasse Dührsen, Joshua S. Catapano et al.|Journal of neurosurgery|2024Cited by 0